Live Breaking News & Updates on Ameritas Investment Partners|Page 2
Stay updated with breaking news from Ameritas investment partners. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Stephens reissued their overweight rating on shares of Vita Coco (NASDAQ:COCO – Free Report) in a research report report published on Thursday, Benzinga reports. They currently have a $31.00 price target on the stock. Several other research analysts have also recently commented on the stock. The Goldman Sachs Group lowered their price target on shares […] ....
CG Oncology, Inc. (NASDAQ:CGON – Get Free Report)’s share price traded up 9.8% on Thursday . The stock traded as high as $30.76 and last traded at $30.75. 161,335 shares were traded during trading, a decline of 76% from the average session volume of 668,246 shares. The stock had previously closed at $28.01. Analyst Upgrades […] ....
Kymera Therapeutics (NASDAQ:KYMR) Shares Down 5.5% dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.
Form N-VPFS AMERITAS LIFE OF NY SEPA For: Dec 31 streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Insider Selling: Protagonist Therapeutics, Inc. (NASDAQ:PTGX) CFO Sells $30,985.74 in Stock theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.